CLINICAL_TRIALS
trial_result
· 2026-06-29
Clinical Trial Results: SPI-1005 Treatment in Severe COVID-19 Patients [Phase 2]
Summary
A Phase 2 trial evaluating SPI-1005 for treatment of severe COVID-19 has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sound Pharmaceuticals, Incorporated | Conditions: Covid19, Coronavirus | Phase 2 | Status: COMPLETED | Results posted: 2026-06-29